NovaBay Pharmaceuticals Inc (NBY) stock price

NovaBay Pharmaceuticals Inc (NBY) is a Healthcare · Biotechnology company listed on NYSE MKT. Price $0.84 (+0.00%), Market cap $0.05B, 52-week low–high $0.43 ~ $19.16.

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for NovaBay Pharmaceuticals Inc are updated in real time on BlackAll Trade.

NovaBay Pharmaceuticals Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current NovaBay Pharmaceuticals Inc (NBY) stock price?

NovaBay Pharmaceuticals Inc trades at $0.84 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.

What is the NovaBay Pharmaceuticals Inc (NBY) market cap?

NovaBay Pharmaceuticals Inc has a market cap of about $0.05B.

What does NovaBay Pharmaceuticals Inc (NBY) do?

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment